Observational studyEpilepsia open2024

The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam.

Bernhard J Steinhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.